-
Novo Nordisk app designed to help hemophilia patients, families
PRINCETON, N.J. — Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.
HemaGo — available for iPhone, iPad and Android devices — is designed to track hemophilia treatment, bleeding episodes and life events, helping people with the condition and their caregivers monitor the details of treatment, including medications, dosing, bleeding information and the disease's effects on life events.